Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/28/2025

Management of Severe Hyperglycemia in Young Adults with Type 2 Diabetes

Initial Assessment and Treatment Strategy

  • For young adults with marked hyperglycemia (A1C ≥8.5%), the American Diabetes Association recommends initiating basal insulin while simultaneously starting or continuing metformin, with a strength of evidence based on high-quality trials 3, 4
  • Guidelines clearly recommend that when A1C levels are very high (>11%), basal insulin should be initiated, particularly when symptoms of hyperglycemia are present or there is evidence of ongoing catabolism (weight loss), as supported by the American Diabetes Association 1, 2
  • With an A1C of 13.5%, the patient has marked hyperglycemia requiring immediate intervention to prevent acute complications and reduce long-term morbidity and mortality, according to the American Diabetes Association 3, 4
  • Insulin therapy should be initiated immediately while restarting oral medications, rather than relying solely on tirzepatide (Mounjaro) and lifestyle changes, as recommended by the American Diabetes Association 1, 2
  • The American Diabetes Association recommends beginning with a long-acting basal insulin analog (insulin glargine or insulin detemir) for rapid reduction of severe hyperglycemia and prevention of metabolic decompensation 5
  • Metformin remains the preferred first-line agent for type 2 diabetes, improving insulin sensitivity and helping with weight management, as stated by the American Diabetes Association 1, 2

Monitoring and Follow-up Plan

  • The American Diabetes Association recommends monitoring blood glucose levels frequently, ideally daily with home glucose monitoring, and scheduling follow-up within 2-4 weeks to assess response and adjust therapy 3, 4
  • Measure A1C every 3 months until target is achieved, as advised by the American Diabetes Association 3, 7
  • Once glycemic control improves and stabilizes, consider tapering insulin if the combination of metformin and tirzepatide maintains adequate control, according to the American Diabetes Association 3, 4

Lifestyle Interventions

  • Implement comprehensive diabetes education and support specific to young adults, focusing on healthy eating patterns and encouraging 30-60 minutes of moderate to vigorous physical activity at least 5 days per week, as recommended by the American Diabetes Association 7
  • Set a weight loss goal of 7-10% of excess weight through a structured program, as advised by the American Diabetes Association 7

Important Considerations and Pitfalls

  • Relying solely on GLP-1 RA (tirzepatide) without insulin in severe hyperglycemia can delay achieving glycemic control and increase risk of acute complications, as warned by the American Diabetes Association 1, 2
  • Provide education on recognizing and managing hypoglycemia, especially with insulin therapy, as recommended by the American Diabetes Association 8
  • Address barriers to medication adherence that led to the current situation through targeted counseling and simplified regimen when possible, as advised by the American Diabetes Association 1

Long-term Strategy

  • Once glycemic control is achieved (A1C approaching target), consider gradually reducing insulin doses while maintaining metformin and tirzepatide, as recommended by the American Diabetes Association 3, 5